Using artificial intelligence to find new drugs faster
‘Instead of having to check millions of molecules, we may check just 20, 100 or maybe up to 3,000 molecules,’ says Jerusalem-based Pepticom
By American Chemical Society —— Bio and Archives--November 6, 2019
Health and Medicine | Comments | Back To Full Article
Peptides are the hottest area of new drug development. Medications derived from these “short” naturally occurring proteins – a midpoint between small molecules and large antibodies — are highly targeted and often much less toxic than other treatments.
It’s no wonder, then, that peptide-derived drugs have become a $20 billion market, expected to grow to $43 billion by 2024, according to Zion Market Research.Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy